Clinical trial: predictive factors for response to gut-directed hypnotherapy for refractory irritable bowel syndrome, a post hoc analysis.

Jade DevenneySyed S HasanJulie MorrisPeter J WhorwellDipesh Harshvadan Vasant

Published in: Alimentary pharmacology & therapeutics (2023)

These data suggest that patients with a higher burden of gastrointestinal and extraintestinal symptoms are most likely to benefit from gut-specific behavioural intervention for refractory IBS. Clinical assessment of gastrointestinal, somatic and psychological symptom profiles may play a role in selecting patients for gut-directed hypnotherapy.

Keyphrases

irritable bowel syndrome
clinical trial
end stage renal disease
randomized controlled trial
ejection fraction
newly diagnosed
prognostic factors
electronic health record
gene expression
patient reported
sleep quality
big data
dna methylation
copy number
machine learning
artificial intelligence
phase ii